Trials of the British Army's Ajax armoured vehicle will be "proceeding cautiously" after they were halted last year, a defence minister has said. A decision was made to stop using the Ajax after ...
Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...
Ajax have been forced to relocate their crucial European play-off semi-final to FC Volendam's modest Kras Stadion due to a clashing Harry Styles concert series at the Johan Cruijff ArenA. The ...
Eli Lilly LLY-0.00%increase; green up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmakerās blood-cancer ...
April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up āto $2.3 billion in cash, as the U.S. drugmaker looks to ...
Today's game between NAC Breda and Ajax will kick-off at Apr 25, 2026, 2:00 PM. TV channel and live stream options for NAC Breda vs Ajax are listed below. In the United States, the match is available ...
Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...
General Dynamics said the safety of soldiers 'is, and has always been, our highest priority'. Trials of the Army's troubled Ajax armoured vehicles will resume "cautiously", with the defence minister ...
Trials of the Army's troubled Ajax armoured vehicles will resume "cautiously", with the defence minister acknowledging more work is needed to "rebuild confidence" in the transportation. Testing of the ...
El objetivo de precio medio a 12 meses para Ajax es de 9,00 EUR, con una estimación alta de 9 EUR y una estimación baja de 9 EUR. Resumiendo las opiniones de nuestros analistas, 0 de ellos recomiendan ...
Company unveils first proof-of concept clinical data of AJ1-11095 in patients with myelofibrosis who have been previously treated with a type I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results